← Eichor
Study identifier: NCT06150703 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles

Condition: In Vitro Fertilization · ICSI Intracytoplasmic Spermatozoid Injection  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhasePhase 3
Planned participants652
Who can joinFemale, 18 Years to 39 Years
Healthy volunteersNo

About this study

The development of stimulation protocols for in vitro fertilisation (IVF) has led to a paradox. It has now been established that obtaining a large number of oocytes is a key to success, but that it is also a risk factor for embryo transfer failure after puncture (disruption of endometrial receptivity due to luteal insufficiency) and a risk factor for complications such as ovarian hyperstimulation syndrome (OHSS).

This description comes directly from the study's public registry record.

Talk to the study team

Maeliss Peigné, MCU-PH  ·  01 48 02 68 56  ·  maeliss.peigne@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Maeliss PeignéBondy, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06150703